Skip to main content
logo
Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
0.7610
-0.0405 (-5.05%)
At close: Oct 23, 2026, 4:00 PM EDT
0.7697
+0.0087 (1.14%)
After-hours: Oct 23, 2026, 7:30 PM EDT

Compass Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
--0.85---
Revenue Growth
------
Gross Profit
--0.85---
Operating Income
-81.09-72.84-56.63-50.36-41.66-31.26
Net Income
-73.45-66.49-49.38-42.49-39.23-82.18
Earnings Per Share
-0.40-0.42-0.36-0.33-0.37-1.31
EPS Growth
------

Cash & Debt
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
179.88208.91126.72152.46186.61144.51
Total Debt
9.639.836.631.732.944.04
Net Cash (Debt)
170.25199.08120.09150.73183.67140.48
Net Cash Growth
86.99%65.78%-20.33%-17.94%30.75%272.20%
Net Cash Per Share
0.941.260.871.191.752.23

Cash Flow & CapEx
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-56.11-49.14-44.86-40.62-34.13-19.67
Capital Expenditures
-0.27-0.03-0.04-0.03-0.21-1.89
Free Cash Flow
-56.38-49.17-44.9-40.65-34.34-21.55
Free Cash Flow Growth
------

Margins
Chart
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
--100.00%---
Operating Margin
---6661.76%---
Pretax Margin
---5808.82%---
Profit Margin
---5808.82%---
FCF Margin
---5282.23%---

Valuation
Chart
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
--234.71---